Indian private healthcare is experiencing rapid expansion into smaller cities, driven by significant investment from global private equity firms. Major buyout groups such as Blackstone, KKR, and Carlyle have been acquiring local hospital chains, nursing homes, and diagnostic companies, aiming to fill gaps in the country’s public health infrastructure.

The push into less-served urban and semi-urban areas comes amid persistent challenges in India’s public healthcare system. Despite government commitments to increase public health spending to 2.5 percent of GDP by 2025, current expenditure remains below 1.5 percent, a level described in a recent parliamentary committee report as inadequate. The public hospital network, though largely free or heavily subsidized, struggles with overcrowding, outdated facilities, shortages of medical staff, and limited equipment—especially outside major metropolitan centers where approximately 70 percent of India’s population resides.

According to the Association of Healthcare Providers India, there is a nationwide shortfall of about 2.4 million hospital beds. This shortfall has helped private hospitals capture a growing share of healthcare services, now accounting for almost 60 percent of hospital admissions and 70 percent of outpatient visits. Private care is widely regarded as offering more modern and higher-quality treatment.

Aster DM Quality Care, backed by Blackstone, exemplifies this trend. Its group chief executive, Varun Khanna, highlighted the viability of hospitals in so-called lower-tier cities, noting that many have populations comparable to those of large cities abroad. Aster currently operates 59 hospitals with more than 10,000 beds and plans to add 5,000 beds within the next three to four years, focusing largely on underserved regions. The group’s hospital near Nagercoil in southern India serves as a case study, providing local residents with access to healthcare services that previously required long and costly travel to bigger cities.

The inflow of private equity into Indian healthcare has been substantial, with over $14.5 billion invested from 2020 to early 2025. In August, KKR announced a $1.4 billion acquisition of Medicover India, which operates nearly 5,000 beds. Industry analysts and executives attribute the growth to factors including an aging population, rising chronic diseases, and increased affluence, which have together expanded demand for better healthcare.

However, the rise of private healthcare has prompted concerns about affordability and equity. Indian households typically pay around 40 percent of health expenses out of pocket, and medical inflation rates in India rank among the highest in Asia, estimated between 12 and 14 percent annually. The parliamentary committee report criticized reliance on private providers, warning that unregulated costs for diagnostics, medicines, and intensive care lead many vulnerable families into debt. The report recommended imposing limits on foreign investment and curbing corporate buyouts to prevent inflated healthcare prices.

Supporters of private investment in healthcare argue that the public sector alone cannot meet the vast unmet demand. An executive from a global private equity fund stressed that, given the enormous healthcare needs in India, private capital is necessary to complement government efforts and expand service capacity.

With hospital chains collectively expected to invest billions and add tens of thousands of beds over the next four years—nearly half in smaller cities—the Indian healthcare landscape is poised for continued transformation marked by a complex interplay between expanding private services and ongoing public health challenges.